Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Mr. Sano
http://www.sec.gov/Archives/edgar/data/1205181/000106594911000177/i3ex51.txt
Looks like Dean has come up with the cash to continue to the finish line once again. 5 mil shares for the attorneys and 15 mil shares to cover loans to 4 third parties. He used his personal shares to accomplish this! I suspect this is what he has been operating on to pay the consultants and keep the lights on in Burbank. Just guessing here, I think he received around 1 mil plus in cash or services.
I wish there was a date noted for the loan exchange but there is not. Any tossed out there would be pure speculation. At least when he said he had financing to continue he truly did. As I said the other evening, Dean always comes up with a way.
I also noted he still has the same Attorney that could not get the S3 form filed correctly on the Crenshire deal until around the 6th attempt. That cost dearly. IMGG did not receive a dime due to it not being completed in 120 days as laid out in the contract.
Books are still Jacked Up IMO.
Anyone here still in Denial about how the Macros effect on ARIAD. Get used to it. It’s going to continue for some time IMO.
As I stated previously, this is a trader’s market for those that.?. can. Lots of shares will be gained by some here.
Hang On
Altounians people do whatever he says and if he would have told his people to buy the PPM it would have been filled allong time ago
Is this opinion, fact or something else?
Just wondering
Sano
You are one of the few level headed posters here. This post is to you,I wont respond to any others comments.
I must agree with most of your post. I do agree the books at IMGG are out of whack to say the least! I dissected the last two 10Ks as they were published.
I agree, It will take another 12 months until this decision has completly unfolded.
I suspect that somehow Dean will get to a FDA Final Decision Line; But we re not there yet. How he will fund it I have no idea. Looking at past history, he always seems to get it done regardless of funds??? But he does.
I think your Groupon comment holds little water: He has not sold all of the shares on the last offering?
I must fully agree with the Monkey A/S statement and Poison Pill vote. Shareholders were FED some BS myself included.
I have grow tired of all the acusations that hold no merit. I posted viabable links that showed the bar is low for the FDA or Gov. to act if they so choose , very recently. They have not. There’s a reason they have not. I won’t elaborate on this. It’s very simple answer, for those that have done their research.
I will continue to drop in from time to time, watching this story unfold.
Good Trading M - Sano :)
J
To all:
Read the post from this evening and ask WHY and then do some research, and ask WHY. Continue to ask for answers to the questions that I asked tonight that were avoided.
Uhh?I think there is a time line question ingrained in your post? Quote: "The CDPHRD assured me that no radiation was emitted at the OH, so there is no reason for me to have been there"
All I asked was your opinion of the Open House. I thought you attended? If you did not, how do you comprise the summation you express?
Did you attend the Open House?
You were there at the Open House that was open to anyone that wanted to attend " Public invite"? "I hate abbreviations"? Please elaborate... What did you see that was not legit? I was unable to attend.
Please enlighten me on what you witnessed good or bad.
Just tell us what you witnessed with your own eyes, even if it’s bad. . Just tell us in your own words.....
We are all EARS!
I just spit coffee all over my keyboard....
I never stated they would lock him up those were your words! I do ask why we have not seen any headlines like these below, if IMGG truly defied the FDA. It seems the bar is very low? Take a read:
http://ducknetweb.blogspot.com/2010/01/fda-directs-us-marshalls-to-seize-77.html
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm237894.htm
http://www.consumerinjurylawyers.com/legal-news/fda-seizes-contaminated-heparin/
http://www.msnbc.msn.com/id/42420216/ns/health-infectious_diseases/t/wipe-maker-shuts-doors-after-us-marshals-arrive-site/
Can you see a pattern here? Now ask yourself? Why the Federal Marshals have not visited IMGG at Burbank. These are just a few examples of the FDA exerting the power they yeild! There are Hundred's of other examples? Why have they not acted on IMGG?
I guess it’s the deficit budget cuts from Congress?
Are you addressing this part of my previous post?
Has anyone considered that the DVIS machine that is off site? could be doing IDE at this time, generating images to be submitted to the FDA for comparison?
As I stated in the same post, I think the FDA laid out the rules very clearly in response to my questions to them here:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=60367647
What I can conclude from my correspondence and what i have read at the FDA site either Dean Janes had permission from the FDA to demo at the OH or the Federal Marshals should have visited already?
What do you think?
I think these are very KEY words in your post SMF quote "subjects who are fully informed of every single individual risk they are exposed to in subjecting themselves to an EXPERIMENTAL device." Not saying its so. Have you read the NDA? By chance did you attend the OH? I did not.
INCORRECT THE FDA APPROVED IDE USE! Please read the link below. This could be how Dean was allowed to demo the DVIS? Only those that signed the NDA know what was in it.
http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/InvestigationalDeviceExemptionIDE/ucm051345.htm
Also read the letter I received from the FDA. They laid it out very clearly IMO.If Dean has not complied with the FDA guidelines they will request the Federal Marshal to confiscate any equipment used outside of their authorization. The rules and consequences are very clear, if you take the time to research and read them. The FDA has a plethora of information on their guidelines.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=60367647
Has anyone considered that the DVIS machine that is off site? could be doing IDE at this time, generating images to be submitted to the FDA for comparison?
Macro Economics
I know this is a touchy subject here! But we all have to consider this. The key subject at this time is EU and how they will deal with their situation? I think all that keep up with current events, know Greece is the tilt? I suspect they will default in 2012.
Not that the USA is in Great shape? But nothing comparison to Greece. It’s amazing that Americans can’t see the trees for the forest. I suspect this next 12 months will be a great trading opportunity for those with the wisdom and guts to do so.
Be prepared for volatility is my predication. I think its just geting started.
BuyonDips
Brian Altounian
Anyone here follow this major shareholder of IMGG "according to the posters here"? Twitter account? He made some serious statements lately. I read them on another board also? I have not read anything about them here? Is anyone here aware of this? May be some of the frequent posters and those that stay on top of everything IMGG can comment?
Just Wondering
Good Job
Well lets see if this PIG can close above 10.
This was orginally posted by DewDiligence at another board. This Overhaul has some critics, including Raymond Damadian, the doctor who invented magnetic resonance imaging technology.
US Patent Overhaul Nears
[Please see #msg-60150853 and the chart in #msg-37325719 for background.]
http://online.wsj.com/article/SB10001424053111904537404576554633952918662.html
›SEPTEMBER 7, 2011
By AMY SCHATZ And DON CLARK
WASHINGTON—A patent-system overhaul nearly a decade in the making is expected to receive final congressional passage this month, significantly altering how anyone with an invention—from a garage tinkerer to a large corporation—will vie for profitable control of that idea's future.
The bill, which passed a key Senate vote Tuesday and is expected to get President Barack Obama's signature, will reverse centuries of U.S. patent policy by awarding patents to inventors who are "first to file" their invention with the U.S. Patent and Trademark Office. Currently the "first to invent" principle reigns, which often spawns costly litigation between dueling inventors.
The new system puts a premium on inventors with the wits—or deep pockets—to dash to the patent office as soon as they discover something useful and non-obvious.
Many big companies say that change will help forestall drawn-out disputes. "You'll end up with a patent system that's more predictable and far more certain," said Bob Armitage, general counsel of drug maker Eli Lilly & Co.
But small inventors fear the first-to-file approach will cause companies to overwhelm patent examiners with applications, a pace of activity individuals can't afford to match. Critics include Raymond Damadian, the doctor who invented magnetic resonance imaging technology and has said the MRI would never have been invented under the proposed rules.
"This is very, very harmful for small companies, and they're by and large completely unaware of what's about to happen," said venture capitalist Gary Lauder. "The biggest harm will come for companies ages zero to one." Right now, entrepreneurs can talk to potential investors and others to gauge the potential for an invention without much risk of the idea will be stolen, he said, and first-to-file reduces that opportunity.
The bill also includes provisions that larger companies have sought for years. They will gain a new way to challenge patents that have just been granted [as is the practice in many countries], and the U.S. Patent and Trademark Office will get the right to set its own fees and hire more examiners. [The USPTO will for the first time be able to keep a portion of the fees it levies on patent applicants for its own purposes instead of turning over 100% of the fees to Congress—see below.]
That could make getting a patent quicker. Currently, there's a three-year wait for patent applications and some patent-office programs—such as a fast lane for applicants that are willing to pay extra fees—are on hold because of funding shortfalls.
"Is it a perfect bill? No," said David Simon, associate general counsel at chip maker Intel Corp., who estimated he has been working on a patent overhaul for nine years. "But it has a lot of good steps forward that will help things."
The Senate voted 93 to five Tuesday to limit debate on the bill, which passed the House in June. Aides said final passage could come by next week, and then the bill would go to President Obama's desk for signature.
Mr. Simon said the new challenge procedure may cut down on patents that shouldn't have been granted and are now seldom tested until costly litigation has begun.
Another provision, he said, would make it harder for patent holders to file blanket suits against dozens of companies in dissimilar industries.
Companies like Intel that manufacture products have often found themselves at odds with companies that live solely on their patents, sometimes buying and selling them like stocks in a portfolio.
But Intellectual Ventures, one of the best-known companies in the latter category, said it generally supports the current version of the legislation, including the post-patent review.
Matt Rainey, the firm's chief counsel for intellectual-property policy, said the bill's provisions giving the patent office more control over its own funding are critical. "If we don't give the patent office the money it needs and the people it needs to carry it out, it could be worse," he said.
Larger companies argue that the change to a first-to-file system will make it easier for companies by bringing the U.S. in line with Europe and Japan.
Already, companies "should be running to the patent office as soon as they can because in the rest of the world you have to," said Stuart Meyer, an intellectual property partner at law firm Fenwick & West.
When Canada instituted a similar change to "first to file" in 1989, the number of individual inventors who filed patents dropped and didn't go back up in the following years, according to new research by a pair of University of Pennsylvania Law School professors.
"To the extent we think the patent systems in the U.S. and Canada are similar, we might expect to see a similar outcome in the U.S.," said David S. Abrams, assistant professor of law, business and public policy at the University of Pennsylvania Law School and a co-author of the study.
In response to the complaints from the small business community, the legislation sets up an ombudsman program to help start-ups and provides new discounts on patent filing fees for small companies.
Passage of the legislation would mark the end of a decade-long battle by companies to persuade Congress to overhaul patent rules and jump-start the slow-moving Patent and Trademark Office. Previous attempts to pass legislation died as various industry groups haggled over details in the bill, but some of the largest disagreements – such as how damages on patent cases are determined – have been settled by the courts.
The Senate passed an earlier version of the bill in March on a 95-5 vote. The House passed its version 304-117 in June. The House bill—the same one the Senate voted on Tuesday—creates a reserve fund for excess patent fees instead of allowing the patent office to automatically keep all the fees its collects.
That displeased some senators who believed the new system might continue to give Congress the leeway to take patent fees and use the money elsewhere, but the objections weren't enough to derail the bill in Tuesday's vote.‹
Well, I'm glad we agree for the most part?... ?... ?....
Mugs
This is true:
the FDA requested a concurrence study be done and a report of the results be sent on 30 or more clinical image pairs (from the same or equivalent patients) that show the ability of the device to provide images of equivalent diagnostic capability to those of a cleared predicate device.
I don’t think they are speaking of a PMA as the previous conversation was speaking of. Yes, they do want images from both machines and even more, if there is more than one predicate device. This can be part of a 501K application.
And yes: Dean did a Piss Poor Job on the first Application. The AI as much as stated this IMO. I honestly don't think he had the DVIS fully functional at that time. No, I'm not sure he does now , but the accounts I here from those that attended the Open House and witnessed the DVIS in action are very good. I wish I could have attended.
Hello All
It's been a long time since I have posted on this board. I commend SMF for the job he has preformed. I feel he has done his best to comply with the I hub rules. If only posters would take the time to read Ihub rules? I’m sure he has asked himself this a thousand times as I did why they dont. The Moderator position is a hard as it gets on any public board. I know just how hard it is. You catch it from both sides and no one is ever happy with the results for long. I was the moderator here for some time.
I have read the accounts from the Open House at Imaging 3. I believe them to be true. This is only half way to the finish line. I think investors should ask them self can the Dominion get through the FDA process? Has Dean Janes hired the people that can get this done? I think we should also look at the dilution that has been placed in the share price along the way with the warrants and PPM. This is neither a pro nor con statement, just examine the company fundamentals as they are. I hope the shareholders will look at the entire situation and make their own decision. I also feel those that took the time to go to the open house are prudent investors.
Best to all
Kingfisher
Yea, it lasted all of 3 minutes. They could have done a 3 paragraph PR with so little to say.
I was disappointed in the content of the call. Basically nothing new. I was looking for new FDA filings for the other intended uses at a minimum!
Hello Flash
I have had some recent messages from past members of your board. I here through the grape vine that Guru is going to attend the open house. I also here he will have Radiologist Professionals with him? There will be many opinions on what is seen, if anything. From my past interactions with Guru I think he will call it like it is? Use your best judgment as always.
KF
Hello Flash, I hope all is good with you. I sold out of IMGG and moved on. I hope for those still invested that things turn around. I won’t be attending the open house.I hope those that are still invested do. Nothing like seeing what is going on with their own eyes, good or bad.
I would like to see 100 SEC and IRS agents show up at home office!
Welcome gpo344
That was a plethora of information in 13 consecutive posts.? Please don’t hold back any information that you can share with the board in the future.
Thank you
Welcome to the board
Yo2
Fortunately I’m debt free these days. I won’t be able to purchase a ranch at 15, but I have my eye on a small farm or a very nice home. I hope some major Pharma makes my decision for me in the next 12 months. I know the Harv will drive the pps for all its worth. I know he doesn’t want to sell, but I will for the right price. That’s around 20 tomorrow and if we reach 17 I would want 25.
BuyonDips
I wonder why he picked 17 for ARIA to be taken out? I would take 27 if we were at 17!
I'd rather buy it on strength as it goes up. I want to buy more, I just don't want to commit any more capital to this market just yet, without re-allocating some of my other positions, which, at the moment, I do not want to do.
AKA- He's making a killing in ARIA and does not want to sell at this time. :)
DFSEX
really like this stock long. 2013 to 2015.
I agree, but I had a 24 month time frame. It appeares you think it will take much longer with the 2013-2015 dates?
Yes, I own this POS
Im thinking the bottom is .50 for obvious reasons. They won’t sell at a loss. It’s a long and time consuming road up from here. I may take 24 months imo. Then again there are 32 mil. shares in this S1 could be some that panic or run out of patience.
Yes, I own this PIG.
BTH
i do agree.....the stock talk from berger is slightly concerning...or hes dead serious....if he starts selling shares after all his stock pumping.....then i will be very concerned.
I agree but he could take advantage of options. I dont think he needs the cash from his shares.
iandy
Anyone that has been listening to Harvey Berger for a number of years knows he is inclined to pump his company at every opportunity.
There's not a CEO out there that doesn't do this to some extent. CEOs are postive even in the worst situations.
New drugs will come when ARIA matures. Postive cash flow will make this much easier. One blockbuster drug will accomplish this. They wont have to make deals for funding.
Lt
The Big boys knew of the critical SA article before it was made public imo. If you look at the charts NEOP had a severe drop prior to the SA article being made public. Some at this board were posting somethings wrong!!!! , looking at the share trade and PPS? They were right............... Just read through the post at that time.
the big boys are loaded and ready to let it fly
Well stated. I agree with your post. I'm long also, but this is not a long term hold for me. I may consider holding a % if this is approved just for a lotto play. I have had several of these pay especially when they received fda approval.
VG4321
Since when is trading over 1 million shares a day thinly traded?
1 mil is not thinly traded. This is the norm cutoff for most traders. That is enough volume to sell or buy at will. Anything less one may be waiting? Today was a nice change for the positive imo
I would love to see volune increase to 20 mil early Wed.
GLTA
EYEBUYSTOX Share Monday, June 20, 2011 6:38:34 PM
Re: R P post# 2112 Post # of 2113
Here's an example:???
Can you provide a chart? Maybe Im missing something here?
BW
Derivitive Indicators-
Although the pick up in trading volume the last few weeks tells you a lot about Ariad's prospects,
The message volume on this board ( not to mention the improvement in general quality) confirms it.
------------------------------------------------------------------------------------------------------------------------------------------
What I would like to see is Institutional Investors taking new positions or adding. Honestly I could care less what this message board volume is. The message board volumes here doesn’t even rate with me in the grand scheme of things. Great info and posters here. Some very sharp people here, but in the end the large cash controls.
It was a good day, and I suspect we will have more in time.
GLTA
Yo2
I don’t disagree with your statement; although I do think ARIA is doing very well with no compounds FDA approved? One on the burner that has met endpoints? I don’t see a huge income if it is approved? I have to stand back and say hem... $10.00
We only know what the company tells us, I assure you they will adorn any PR they make! This is what CEOs do best.